<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025102</url>
  </required_header>
  <id_info>
    <org_study_id>gymoese007</org_study_id>
    <nct_id>NCT01025102</nct_id>
  </id_info>
  <brief_title>The Addition of Sufentanil Interscalene Block in Shoulder Surgery</brief_title>
  <official_title>Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bent Gymoese Jorgensen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Frederiksberg University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects and side effects of interscale block
      performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare the duration of postoperative analgesia and
      supplemental opioid consumption and side effects of interscale block performed with Naropin
      0.1% cum sufentanil or Naropin 0.1% in shoulder surgery
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to experience of moderate to severe postoperative pain</measure>
    <time_frame>On day of surgery and 1., 2. and 3. postop. day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>On day of surgery and 1., 2. and. 3. postop. day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Shoulder Surgery</condition>
  <arm_group>
    <arm_group_label>Naropin 0.1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naropin 0.1% cum sufentanil</intervention_name>
    <description>20ml of Naropin 0.1% cum sufentanil 1mikrog per ml</description>
    <arm_group_label>Naropin 0.1%</arm_group_label>
    <other_name>Local analgetic</other_name>
    <other_name>Ropivacain</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

          -  Age 18-80

          -  Shoulder surgery performed under interscalene block and general anesthesia

        Exclusion Criteria:

          -  Contraindication of interscalene block

          -  Severe chronic obstructive lung disease

          -  Non-cooperative patient

          -  Intolerance to opioids

          -  Pregnancy

          -  Rheumatoid arthritis and diabetes with peripheral polyneuropathy

          -  Chronic pain or daily opioid intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bent G JÃ¸rgensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthetic Clinic, Frederiksberg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anesthetic Clinic, Frederiksberg University Hospital</name>
      <address>
        <city>Frederiksberg</city>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2009</study_first_submitted>
  <study_first_submitted_qc>December 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2009</study_first_posted>
  <last_update_submitted>March 30, 2013</last_update_submitted>
  <last_update_submitted_qc>March 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Frederiksberg University Hospital</investigator_affiliation>
    <investigator_full_name>Bent Gymoese Jorgensen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

